XON $5.69 0.19 (3.2%)

    XON Profile

    XON trades on the NASDAQ.

    MEMBERSHIP
    --
    SECTOR
    Health Care
    MARKET CAPITALIZATION

    $960 Million

    Intrexon is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

    XON Earnings

    EPS

    -0.35

    P/E

    --

    Q2 Earnings for Apr, May & Jun

    Thu, Aug 8, 2019

    Since Earnings Report

    XON -24.0%

    Q3 Earnings for Jul, Aug & Sep

    Tue, Nov 12, 2019

    Since Earnings Report

    XON +2.9%

    XON Dividend

    Dividend Yield

    0.00%

    Dividend Rate

    $0.00

    Ex-Dividend Date

    --

    Dividend Pay Date

    --

    Dividend Frequency

    --

    Dividend Payments

    --

    XON Charts

    52WL $3.95
    52WH $9.10
    All-Time $68.78


    XON Industry Competitors


    BIOTECH & PHARMA
    Johnson & Johnson
    Merck
    Pfizer
    Bristol-Myers Squibb
    Amgen
    Novo Nordisk A/S
    AbbVie
    Eli Lilly
    Sanofi SA (ADR)
    Gilead Sciences



    Symbol MC DY Price Day YTD
    XON $0.96 0.00% $5.69 -3.2% -20.4%






        TOP    




    info@symbolsurfing.com


    Symbol Surfing

    ©2019 Symbol Surfing All Rights Reserved.

    Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

    Cookies Policy Terms Of Service Privacy Policy